Startseite Position of immunological techniques in screening in clinical toxicology
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Position of immunological techniques in screening in clinical toxicology

  • Steve George
Veröffentlicht/Copyright: 21. September 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

There is a continuing increase in the use of immunological techniques in the field of clinical toxicology. This is primarily due to the rapidity by which analytical results are now required, and can be obtained, following the testing of individuals for drug use. There has recently been an increase in the repertoire of assays now available to testing laboratories (e.g., buprenorphine and heroin metabolite assays), with the techniques themselves becoming increasingly more specific for the drugs and/or metabolites being monitored (e.g., methadone metabolite assays). The near patient testing (NPT), or point-of-care testing (POCT), devices are now several generations forward from their inception, with some tests now approaching the sensitivity and specificity of automated laboratory-based methods. This review has been collated from the literature to illustrate some of the possible reasons for the move towards the increasing use of immunological techniques, and to highlight some of the advantages and disadvantages associated with such drug screening methods. In particular, it has been shown that it is important to determine, monitor and review the knowledge and training of the individual using the technique. In addition, quality control and quality assessment are paramount to ensure the validity of any drug testing being performed. It has also been shown that it is vital to maintain and develop the relationships between the staff performing the testing, the laboratory (if the testing is performed using NPT devices), and the clinicians utilising the results obtained from drug testing. Without these links, interpretive errors could arise which could adversely affect the diagnosis and management of patients.


Corresponding author: Dr. Steve George, Toxicology Laboratory, City Hospital NHS Trust, Birmingham, UK. E-mail:

References

1 Muckter H. What is toxicology and how does toxicity occur? Best Pract Res Clin Anaesthesiol 2003; 17:5–27.10.1053/bean.2003.0270Suche in Google Scholar

2 Walker S, Johnston A. Laboratory screening of body fluids in self poisoning and drug abuse. Ann Acad Med Singapore 1991; 20:91–4.Suche in Google Scholar

3 Hoffman RJ, Nelson L. Rational use of toxicology testing in children. Curr Opin Pediatr 2001; 13:183–8.10.1097/00008480-200104000-00017Suche in Google Scholar

4 Armbruster DA, Krolak JM. Screening for drugs of abuse with the Roche ONTRAK assays. J Anal Toxicol 1992; 16:172–5.10.1093/jat/16.3.172Suche in Google Scholar

5 Rohrich J, Schmidt K, Bratzke H. Application of the novel immunoassay TRIAGE to a rapid detection of antemortem drug abuse. J Anal Toxicol 1994; 18:407–14.10.1093/jat/18.7.407Suche in Google Scholar

6 George S, Braithwaite RA. Use of on-site testing for drugs of abuse. Clin Chem 2002; 48:1639–46.10.1093/clinchem/48.10.1639Suche in Google Scholar

7 Beck O, Kraft M, Moeller MR, Smith BL, Schneider S, Wennig R. Frontline® immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens. Ann Clin Biochem 2000; 37:199–204.10.1258/0004563001899005Suche in Google Scholar

8 George S, Braithwaite RA. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening. Addiction 1995; 90:967–70.10.1111/j.1360-0443.1995.tb03505.xSuche in Google Scholar

9 George S, Braithwaite RA. The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs-of-abuse assays. J Anal Toxicol 1996; 20:195–6.10.1093/jat/20.3.195Suche in Google Scholar

10 Clear Test, USA. www.cleartest.com. Accessed 30/06/04.Suche in Google Scholar

11 Elite Detox, USA. www.elitedetox.com. Accessed 30/06/04.Suche in Google Scholar

12 Urea Sample, USA. www.ureasample.com. Accessed 30/06/04.Suche in Google Scholar

13 Wolff K, Farrell M, Marsden J, Monteiro MG, Ali R, Welch S, et al. A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction 1999; 94:1279–98.10.1046/j.1360-0443.1999.94912792.xSuche in Google Scholar

14 Wu AH, Hill DW, Crouch D, Hodnett CN, McCurdy HH. Minimal standards for the performance and interpretation of toxicology tests in legal proceedings. J Forensic Sci 1999; 44:516–22.Suche in Google Scholar

15 Stewart CP, Stolman A. The toxicologist and his work. In: Stewart CP, Stolman A, editors. Toxicology mechanisms and analytical methods. vol. 1. London: Academic Press, 1960.Suche in Google Scholar

16 Walberg CB, Pantlik VA, Lundberg GD. Hospital toxicology: role of the laboratory. In: Thoma JJ, Bondo PB, Sunshine I, editors. Guidelines for analytical toxicology programs, vol. 1. Cleveland, OH: CRC Press Inc., 1977.Suche in Google Scholar

17 The Department of Chemical and Forensic Sciences, University of Bradford, UK. www.castleviewuk.com. Accessed 30/06/04.Suche in Google Scholar

18 Shannon M, Saladino R, McCarty D, Parker KM, Scott L, Brown G, et al. Clinical evaluation of an acetaminophen meter for the rapid diagnosis of acetaminophen intoxication. Ann Emerg Med 1990; 19:1133–6.10.1016/S0196-0644(05)81517-3Suche in Google Scholar

19 Peat MA. Advances in forensic toxicology. Clin Lab Med 1998; 18:263–78.10.1016/S0272-2712(18)30171-9Suche in Google Scholar

20 Eskridge KD, Guthrie SK. Clinical issues associated with urine testing of substances of abuse. Pharmacotherapy 1997; 17:497–510.Suche in Google Scholar

21 Cox MN, Baum CR. Toxicology reviews: immunoassay in detecting drugs of abuse. Pediatr Emerg Care 1998; 14:372–5.10.1097/00006565-199814050-00017Suche in Google Scholar

22 Durback LF, Scharman EJ, Brown BS. Emergency physicians perceptions of drug screens at their own hospitals. Vet Hum Toxicol 1998; 40:234–7.Suche in Google Scholar

23 Wu AH, Wong SS, Johnson KG, Callies J, Shu DX, Dunn WE, et al. Evaluation of the Triage system for emergency drugs-of-abuse testing in urine. J Anal Toxicol 1993; 17:241–5.10.1093/jat/17.4.241Suche in Google Scholar PubMed

24 Koch TR, Raglin RL, Kirk S, Bruni JF. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse. J Anal Toxicol 1994; 18:168–72.10.1093/jat/18.3.168Suche in Google Scholar PubMed

25 Bogema S, Schwartz R, Godwin I. Evaluation of the Keystone Diagnostics Quik Test using previously screened urine specimens. J Anal Toxicol 1988; 12:272–3.10.1093/jat/12.5.272Suche in Google Scholar PubMed

26 Kaplan RM, Fochtman F, Brunett P, White C, Heller MB. An analysis of clinical toxicology urine specimens using the KDI Quik test. J Toxicol Clin Toxicol 1989; 27:369–73.10.3109/15563658909000357Suche in Google Scholar PubMed

27 Schwartz RH, Bogema S, Thorne MM. Evaluation of the Keystone Diagnostic Quik Test. A paper chromatography test for drugs of abuse in urine. Arch Pathol Lab Med 1989; 113:363–4.Suche in Google Scholar

28 Schwartz RH, Bogema S, Thorne MM. Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine specimens. Pediatr Emerg Care 1990; 6:147–9.10.1097/00006565-199006000-00022Suche in Google Scholar PubMed

29 Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Validity testing of the EZ-SCREEN cannabinoid test. J Anal Toxicol 1993; 17:292–8.10.1093/jat/17.5.292Suche in Google Scholar PubMed

30 Ros JJ, Pelders MG, Egberts AC. Performance of Abusign drugs-of-abuse slide tests with particular emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS. J Anal Toxicol 1998; 22:40–4.10.1093/jat/22.1.40Suche in Google Scholar PubMed

31 Korte T, Pykalainen J, Lillsunde P, Seppala T. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine. J Anal Toxicol 1997; 21:49–53.10.1093/jat/21.1.49Suche in Google Scholar PubMed

32 Brown ER, Jarvie DR, Simpson D. Evaluation of Bionike one-step tests for the detection of drugs of abuse in urine. Ann Clin Biochem 1997; 34:74–80.10.1177/000456329703400111Suche in Google Scholar

33 Wennig R, Moeller MR, Haguenoer JM, Marocchi A, Zoppi F, Smith BL, et al. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine. J Anal Toxicol 1998; 22:148–55.10.1093/jat/22.2.148Suche in Google Scholar

34 Phillips JE, Bogema S, Fu P, Furmaga W, Wu AH, Zic V, et al. Signify ER Drug Screen Test evaluation: comparison to Triage Drug of Abuse Panel plus tricyclic antidepressants. Clin Chim Acta 2003; 328:31–8.10.1016/S0009-8981(02)00240-1Suche in Google Scholar

35 Ferrara SD, Tedeschi L, Frison G, Brusini G, Castagna F, Bernardelli B, et al. Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques. J Anal Toxicol 1994; 18:278–91.10.1093/jat/18.5.278Suche in Google Scholar PubMed

36 Schilling RF, Bidassie B, El-Bassel N. Detecting cocaine and opiates in urine: comparing three commercial assays. J Psychoactive Drug 1999; 31:305–13.10.1080/02791072.1999.10471761Suche in Google Scholar PubMed

37 Crouch DJ, Cheever ML, Andrenyak DM, Kuntz DJ, Loughmiller DL. A comparison of ONTRAK TESTCUP, Abuscreen ONTRAK, Abuscreen ONLINE, and GC/MS urinalysis test results. J Forensic Sci 1998; 43:35–40.10.1520/JFS16086JSuche in Google Scholar

38 Buchan BJ, Walsh JM, Leaverton PE. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers. J Forensic Sci 1998; 43:395–9.10.1520/JFS16154JSuche in Google Scholar

39 George S, Braithwaite RA. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening. Addiction 1995; 90:227–32.10.1111/j.1360-0443.1995.tb01040.xSuche in Google Scholar

40 Taylor EH, Oertli EH, Wolfgang JW, Mueller E. Accuracy of five on-site immunoassay drugs-of-abuse testing devices. J Anal Toxicol 1999; 23:119–24.10.1093/jat/23.2.119Suche in Google Scholar PubMed

41 Crouch DJ, Frank JF, Farrell LJ, Karsch HM, Klaunig JE. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices. J Anal Toxicol 1998; 22:493–502.10.1093/jat/22.6.493Suche in Google Scholar PubMed

42 Crouch DJ, Hersch RK, Cook RF, Frank JF, Walsh JM. A field evaluation of five on-site drug-testing devices. J Anal Toxicol 2002; 26:493–9.10.1093/jat/26.7.493Suche in Google Scholar

43 Peace MR, Tarnai LD, Poklis A. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine. J Anal Toxicol 2000; 24:589–94.10.1093/jat/24.7.589Suche in Google Scholar

44 Leino A, Saarimies J, Gronholm M, Lillsunde P. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. Scand J Clin Lab Invest 2001; 61:325–31.10.1080/00365510152379067Suche in Google Scholar

45 Kadehjian LJ. Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens. J Anal Toxicol 2001; 25:670–9.10.1093/jat/25.8.670Suche in Google Scholar

46 Lillsunde P, Michelson L, Forsstrom T, Korte T, Schultz E, Ariniemi K, et al. Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety. Forensic Sci Int 1996; 77:191–210.10.1016/0379-0738(95)01862-XSuche in Google Scholar

47 Keller T, Schneider A, Dirnhofer R, Jungo R, Meyer W. Fluorescence polarization immunoassay for the detection of drugs of abuse in human whole blood. Med Sci Law 2000; 40:258–62.10.1177/002580240004000312Suche in Google Scholar

48 Moriya F, Hashimoto Y. Application of the Triage panel for drugs of abuse to forensic blood samples. Nippon Hoigaku Zasshi 1996; 50:50–6.Suche in Google Scholar

49 Moriya F, Hashimoto Y. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples. Nippon Hoigaku Zasshi 1997; 51:214–9.Suche in Google Scholar

50 Rasanen I, Neuvonen M, Ojanpera I, Vuori E. Benzodiazepine findings in blood and urine by gas chromatography and immunoassay. Forensic Sci Int 2000; 112:191–200.10.1016/S0379-0738(00)00273-5Suche in Google Scholar

51 Hino Y, Ojanpera I, Rasanen I, Vuori E. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Forensic Sci Int 2003; 131:148–55.10.1016/S0379-0738(02)00430-9Suche in Google Scholar

52 Mokhlesi B, Leiken JB, Murray P, Corbridge TC. Adult toxicology in critical care: part I: general approach to the intoxicated patient. Chest 2003; 123:577–92.10.1378/chest.123.2.577Suche in Google Scholar PubMed

53 Chen JS, Chang KJ, Charng RC, Lai SJ, Binder SR, Essien H. The development of a broad-spectrum toxicology screening program in Taiwan. J Toxicol Clin Toxicol 1995; 33:581–9.10.3109/15563659509010613Suche in Google Scholar PubMed

54 Stewart MJ, Moar JJ, Mwesigwa J, Kokot M. Forensic toxicology in urban South Africa. J Toxicol Clin Toxicol 2000; 38:415–9.10.1081/CLT-100100951Suche in Google Scholar

55 Christakis-Hampsas M, Tutudakis M, Tsatsakis AM, Assithianakis P, Alegakis A, Katonis PG, et al. Acute poisonings and sudden deaths in Crete: a five-year review (1991–1996). Vet Hum Toxicol 1998; 40:228–30.Suche in Google Scholar

56 Morris RG, Kennedy M, Kiloh N. Survey of intensive care units and availability of drug assays in Australasia. Ther Drug Monit 2001; 23:295–7.10.1097/00007691-200106000-00019Suche in Google Scholar

57 Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem 2003; 49:357–79.10.1373/49.3.357Suche in Google Scholar

58 Weinman SA. Emergency management of drug overdose. Crit Care Nurse 1993; 13:45–51.10.4037/ccn1993.13.6.45Suche in Google Scholar

59 Buylaert WA. Coma induced by intoxication. Acta Neurol Belg 2000; 100:221–4.Suche in Google Scholar

60 Liang HK. Clinical evaluation of the poisoned patient and toxic syndromes. Clin Chem 1996; 42:1350–5.10.1093/clinchem/42.8.1350Suche in Google Scholar

61 Watson ID. Laboratory support for the poisoned patient. Ther Drug Monit 1998; 20:490–7.10.1097/00007691-199810000-00008Suche in Google Scholar

62 Giorgi DF, Jagoda A. Poisoning and overdose. Mt Sinai J Med 1997; 64:283–91.Suche in Google Scholar

63 Merigian KS, Blaho K. Diagnosis and management of the drug overdose patient. Am J Ther 1997; 4:99–113.10.1097/00045391-199702000-00008Suche in Google Scholar

64 Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain 2002; 18:S76–82.10.1097/00002508-200207001-00009Suche in Google Scholar

65 Henretig FM. Special considerations in the poisoned pediatric patient. Emerg Med Clin North Am 1994; 12:549–67.10.1016/S0733-8627(20)30442-9Suche in Google Scholar

66 Goepp JG. Pediatric poisonings. Clin Chem 1996; 42:1356–60.10.1093/clinchem/42.8.1356Suche in Google Scholar

67 Kyle PB, Spencer JL, Purser CM, Eddleman KC, Hume AS. Suspected pediatric ingestions: effectiveness of immunoassay screens vs. gas chromatography/mass spectroscopy in the detection of drugs and chemicals. J Toxicol Clin Toxicol 2003; 41:919–25.10.1081/CLT-120026511Suche in Google Scholar

68 Schwartz JG, Stuckey JH, Prihoda TJ, Kazen CM, Carnahan JJ. Hospital-based toxicology: patterns of use and abuse. Tex Med 1990; 86:44–51.Suche in Google Scholar

69 Moritz F, Goulle JP, Girault C, Clarot F, Droy JM, Muller JM. Toxicological analysis in agitated patients. Intensive Care Med 1999; 25:852–4.10.1007/s001340050964Suche in Google Scholar

70 Hoffman RJ, Nelson L. Rational use of toxicology testing in children. Curr Opin Pediatr 2001; 13:183–8.10.1097/00008480-200104000-00017Suche in Google Scholar

71 Walker S, Johnston A. Laboratory screening of body fluids in self poisoning and drug abuse. Ann Acad Med Singapore 1991; 20:91–4.Suche in Google Scholar

72 Bogusz MJ, al Tufail M, Hassan H. How natural are ‘natural herbal remedies’? A Saudi perspective. Adverse Drug React Toxicol Rev 2002; 21:219–29.10.1007/BF03256198Suche in Google Scholar

73 Fraser AD, Coffin L, Worth D. Drug and chemical metabolites in clinical toxicology investigations: the importance of ethylene glycol, methanol and cannabinoid metabolite analyses. Clin Biochem 2002; 35:501–11.10.1016/S0009-9120(02)00325-9Suche in Google Scholar

74 Kalasinsky KS, Schaefer T, Binder SR. Forensic application of an automated drug-profiling system. J Anal Toxicol 1995; 19:412–8.10.1093/jat/19.6.412Suche in Google Scholar

75 Polettini A, Groppi A, Vignali C, Montagna M. Fully-automated systematic toxicological analysis of drugs, poisons, and metabolites in whole blood, urine, and plasma by gas chromatography-full scan mass spectrometry. J Chromatogr B Biomed Sci Appl 1998; 713:265–79.10.1016/S0378-4347(98)00062-0Suche in Google Scholar

76 Nyanda AM, Nunes MG, Ramesh A. A simple high-performance liquid chromatography method for the quantitation of tricyclic antidepressant drugs in human plasma or serum. J Toxicol Clin Toxicol 2000; 38:631–6.10.1081/CLT-100102012Suche in Google Scholar

77 Ferrara SD, Brusini G, Maietti S, Frison G, Castagna F, Allevi S, et al. Proficiency testing for psychoactive substances in Italy. Int J Legal Med 1999; 113:50–4.10.1007/s004140050279Suche in Google Scholar

78 Wilson JF, Toseland PA, Capps NE, Sandle LN, Smith BL, Sweeney G, et al. External quality assessment of laboratory performance in analysis of toxicological cases. Forensic Sci Int 2001; 121:27–32.10.1016/S0379-0738(01)00449-2Suche in Google Scholar

79 Dawson AH, Whyte IM. Therapeutic drug monitoring in drug overdose. Br J Clin Pharmacol 1999; 48:278–83.10.1046/j.1365-2125.1999.00033.xSuche in Google Scholar

80 Fleischman A, Chiang VW. Carbamazepine overdose recognized by a tricyclic antidepressant assay. Pediatrics 2001; 107:176–7.10.1542/peds.107.1.176Suche in Google Scholar

81 Keim ME, Bartfield JM, Raccio-Robak N, Abhyankar VV, Salluzzo RF. Accuracy of an enzymatic assay device for serum ethanol measurement. J Toxicol Clin Toxicol 1999; 37:75–81.10.1081/CLT-100102411Suche in Google Scholar

82 Osterloh JD. Utility and reliability of emergency toxicologic testing. Emerg Med Clin North Am 1990; 8:693–723.10.1016/S0733-8627(20)30268-6Suche in Google Scholar

83 Valentine JL, Komoroski EM. Use of a visual panel detection method for drugs of abuse: clinical and laboratory experience with children and adolescents. J Pediatr 1995; 126:135–40.10.1016/S0022-3476(95)70517-1Suche in Google Scholar

84 Mastrovitch TA, Bithoney WG, DeBari VA, Nina AG. Point-of-care testing for drugs of abuse in an urban emergency department. Ann Clin Lab Sci 2002; 32:383–6.Suche in Google Scholar

85 de la Torre R, Domingo-Salvany A, Badia R, Gonzalez G, McFarlane D, San L, et al. Clinical evaluation of the Triage analytic device for drugs-of-abuse testing. Clin Chem 1996; 42:1433–8.10.1093/clinchem/42.9.1433Suche in Google Scholar

86 Inuzuka S, Hayashida M, Nihira M. An investigation of drug abuse and the utility of toxicology screening for use in emergency centers. Nippon Ika Daigaku Zasshi 1997; 64:344–52.10.1272/jnms1923.64.344Suche in Google Scholar

87 Poklis A, Edinboro LE, Lee JS, Crooks CR. Evaluation of a colloidal metal immunoassay device for the detection of tricyclic antidepressants in urine. J Toxicol Clin Toxicol 1997; 35:77–82.10.3109/15563659709001169Suche in Google Scholar

88 Yoshioka T, Kohriyama K, Kondo R, Goto K, Yashiki M. Clinical evaluation of triage as drug-of-abuse test kit. Chudoku Kenkyu 2003; 16:63–71.Suche in Google Scholar

89 Peace MR, Poklis JL, Tarnai LD, Poklis A. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments. J Anal Toxicol 2002; 26:500–3.10.1093/jat/26.7.500Suche in Google Scholar

90 Hicks JM, Haeckel R, Price CP, Lewandrowski K, Wu AH. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta 2001; 303:1–17.10.1016/S0009-8981(00)00400-9Suche in Google Scholar

91 Taylor RL, Cohan SL, White JD. Comprehensive toxicology screening in the emergency department: an aid to clinical diagnosis. Am J Emerg Med 1985; 3:507–11.10.1016/0735-6757(85)90161-5Suche in Google Scholar

92 Baskin LB, Morgan DL. Drugs detected in patients suspected of acute intoxication. Tex Med 1997; 93:50–58.Suche in Google Scholar

93 Sugarman JM, Rodgers GC, Paul RI. Utility of toxicology screening in a pediatric emergency department. Pediatr Emerg Care 1997; 13:194–7.10.1097/00006565-199706000-00005Suche in Google Scholar

94 Perrone J, De Roos F, Jayaraman S, Hollander JE. Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med 2001; 19:49–51.10.1053/ajem.2001.20003Suche in Google Scholar

95 Yang JM, Lewandrowski KB. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT). Clin Chim Acta 2001; 307:27–32.10.1016/S0009-8981(01)00457-0Suche in Google Scholar

96 Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta 2002; 315:125–35.10.1016/S0009-8981(01)00714-8Suche in Google Scholar

97 Belfer RA, Klein BL, Boenning DA, Soldin SJ. Emergency department evaluation of a rapid assay for detection of cocaine metabolites in urine specimens. Pediatr Emerg Care 1996; 12:113–5.10.1097/00006565-199604000-00013Suche in Google Scholar

98 Kranzler HR, Stone J, McLaughlin L. Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable. Drug Alcohol Depend 1995; 40:55–62.10.1016/0376-8716(95)01188-9Suche in Google Scholar

99 Towt J, Tsai SC, Hernandez MR, Kilmov AD, Kravec CV, Rouse SL, et al. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs. J Anal Toxicol 1995; 19:504–10.10.1093/jat/19.6.504Suche in Google Scholar PubMed

100 Steindel SJ, Howanitz PJ. Physician satisfaction and emergency department laboratory test turnaround time. Arch Pathol Lab Med 2001; 125:863–71.10.5858/2001-125-0863-PSAEDLSuche in Google Scholar PubMed

101 Flanagan RJ, Widdop B, Ramsey JD, Loveland M. Analytical toxicology. Hum Toxicol 1988; 7:489–502.10.1177/096032718800700517Suche in Google Scholar PubMed

102 Flanagan RJ. The poisoned patient: the role of the laboratory. Br J Biomed Sci 1995; 52:202–13.Suche in Google Scholar

103 Badia R, Segura J, Artola A, de la Torre R. Survey on drugs-of-abuse testing in the European Union. J Anal Toxicol 1998; 22:117–26.10.1093/jat/22.2.117Suche in Google Scholar PubMed

104 National Poisons Information Service; Association of Clinical Biochemists. Laboratory analyses for poisoned patients: joint position paper. Ann Clin Biochem 2002; 39:328–39.10.1258/000456302760042083Suche in Google Scholar PubMed

105 Hepler BR, Sutheimer CA, Sunshine I. The role of the toxicology laboratory in emergency medicine. J Toxicol Clin Toxicol 1982; 19:353–65.10.3109/15563658208992489Suche in Google Scholar PubMed

106 Hepler BR, Sutheimer CA, Sunshine I. The role of the toxicology laboratory in emergency medicine. II: study of an integrated approach. J Toxicol Clin Toxicol 1984; 22:503–28.10.3109/15563658408992581Suche in Google Scholar PubMed

107 Hepler BR, Sutheimer CA, Sunshine I. Role of the toxicology laboratory in the treatment of acute poisoning. Med Toxicol 1986; 1:61–75.10.1007/BF03259828Suche in Google Scholar PubMed

108 Braithwaite RA, Jarvie DR, Minty PS, Simpson D, Widdop B. Screening for drugs of abuse. I: opiates, amphetamines and cocaine. Ann Clin Biochem 1995; 32:123–53.10.1177/000456329503200203Suche in Google Scholar PubMed

109 Badia R, de la Torre R, Corcione S, Segura J. Analytical approaches of European Union laboratories to drugs of abuse analysis. Clin Chem 1998; 44:790–9.10.1093/clinchem/44.4.790Suche in Google Scholar

110 Pechard A, Besson AS, Mialon A, Berny C, Manchon M. Critical analysis of different methods used for toxicology screening in emergency laboratory. Ann Biol Clin (Paris) 1999; 57:525–37.Suche in Google Scholar

111 Lee V, Kerr JF, Braitberg G, Louis WJ, O’Callaghan CJ, Frauman AG, et al. Impact of a toxicology service on a metropolitan teaching hospital. Emerg Med (Fremantle) 2001; 13:37–42.10.1046/j.1442-2026.2001.00175.xSuche in Google Scholar PubMed

Published Online: 2011-9-21
Published in Print: 2004-11-1

© Walter de Gruyter

Heruntergeladen am 8.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.249/html
Button zum nach oben scrollen